SmarTrend analyzes over 5,000 stocks simultaneously on an intraday basis using its pattern recognition technology to give you real-time alerts for stocks on the move -- so you can maximize your trading results. Let our system increase your market awareness.
News Watch
- 6/30/2009 2:45:28 PM
By Chip Brian, SmarTrend Analytics Team
Shares of Geron (NASDAQ:GERN) are soaring today, up 13.6%, after the company announced that it is teaming up with General Electric's (NYSE:GE) health unit to make stem cell-based drug discovery tests and products. Genron has granted GE Healthcare an exclusive license to its portfolio covering the growth of human embryonic stem cells.
Contact Chip Brian
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com. Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html
|
